Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
Andrew W Roberts, Stephan Stilgenbauer, John F Seymour, David CS Huang
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017
Awarded by National Health and Medical Research Council of Australia
Awarded by Leukemia & Lymphoma Society
Awarded by Victorian Cancer Agency
Awarded by DFG
Research by A.W. Roberts and D.C.S. Huang is supported by fellowships and grants from the National Health and Medical Research Council of Australia (1079560, 1043149), the Leukemia & Lymphoma Society (7001-13), the Victorian Cancer Agency (TRP13041), and the Australian Cancer Research Foundation. S. Stilgenbauer received support from EC TransCan program (FIRE CLL), DFG (SFB1074 subproject B1), and BMBF (PReCISE).